Inflammatory lipid mediators in adipocyte function and obesity. (Q37680661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Inflammatory lipid mediators in adipocyte function and obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

David P. Fairlie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Johannes B. Prins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Bruce D Hammock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lindsay Brown

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

71-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20098448%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2009.264

17 January 2020

exact match

0 references

cites work

Obesity: the two faces of fat

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Mechanisms linking obesity with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

31 March 2020

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

The metabolic syndrome--a new worldwide definition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Is obesity an inflammatory condition?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Lipid overload and overflow: metabolic trauma and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Expansion and contraction: the mighty, mighty fatty acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inflammation, stress, and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Elevated C-reactive protein levels in overweight and obese adults

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

31 March 2020

12 December 2020

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Neutrophil activation in morbid obesity, chronic activation of acute inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Insulin as an anti-inflammatory and antiatherogenic modulator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Effect of chronic aspirin administration on an experimental model of metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Role of inflammation in atherosclerosis associated with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Pleiotropic effects of statins: implications for a wide range of diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Evidence for a potent antiinflammatory effect of rosiglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Autophagy regulates lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Regulation of lipolysis in adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Before they were fat: adipocyte progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Lysophosphatidic acid synthesis and release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Obesity is associated with macrophage accumulation in adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Normalization of obesity-associated insulin resistance through immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inflammation and metabolic disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

T-ing up inflammation in fat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Points of control in inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Origin and physiological roles of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Preadipocyte conversion to macrophage. Evidence of plasticity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Keynote review: the adipocyte as a drug discovery target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Cellular and molecular aspects of adipose tissue development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Adipogenesis and obesity: rounding out the big picture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

The link between insulin resistance syndrome and inflammatory markers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Adipose tissue arachidonic acid and the metabolic syndrome in Costa Rican adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Long-chain polyunsaturated fatty acids in plasma lipids of obese children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Group IVA phospholipase A2 is associated with the storage of lipids in adipose tissue and liver.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Phospholipase A(2) regulation of arachidonic acid mobilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Genetic and pharmacological analysis of prostanoid receptor function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Prostanoid receptor heterogeneity through alternative mRNA splicing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Prostaglandin E receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

31 March 2020

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Prostanoids and prostanoid receptors in signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Secretory, endocrine and autocrine/paracrine function of the adipocyte

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Arachidonic acid metabolites of the lipoxygenase as well as the cyclooxygenase pathway may be involved in regulating preadipocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Regulation of leptin release by mammalian adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Endogenous 15-deoxy-Delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Proliferation and differentiation of rat adipose precursor cells in chemically defined medium: differential action of anti-adipogenic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Protein regulators of eicosanoid synthesis: role in inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Emerging roles for eicosanoids in renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

31 March 2020

12 December 2020

12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Resolution of inflammation: the beginning programs the end

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Action of epoxyeicosatrienoic acids on cellular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Expression and regulation of soluble epoxide hydrolase in adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

TNFalpha is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Targeting the endocannabinoid system: to enhance or reduce?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Platelet-activating factor acetylhydrolase concentration in children with abdominal obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

End of the line for cannabinoid receptor 1 as an anti-obesity target?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

The obesity pipeline: current strategies in the development of anti-obesity drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Inflammation: the link between insulin resistance, obesity and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

IKK-beta links inflammation to obesity-induced insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Obesity, Inflammation, and Insulin Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.264

Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.

31 March 2020

1 reference

12 December 2020

Leukotriene Receptors: State of the Art

1 reference

12 December 2020

Some new aspects on adipose tissue development

1 reference

12 December 2020

Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression.

1 reference

12 December 2020

Troglitazone reduces the expression of PPARgamma while stimulating that of PPARalpha in mononuclear cells in obese subjects

1 reference

12 December 2020

Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture

1 reference

12 December 2020

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

1 reference

12 December 2020

1 reference

12 December 2020